For Clinicians
ImuDx Testing
Begin ImuDx Testing
Would you like to join our clinics in piloting the ImuDx program? Please contact us to arrange a webinar or in-person visit.
ImuDx Testing Populations
Patients with any type of cancer who are being considered for anti-PD1 or anti-PDL1 therapy are eligible for testing.
This test predicts the risk of developing immune related adverse events in response to anti-PD1 or anti-PDL1 treatment.
Already performing ImuDx Testing?
ImuDx ordering takes place by first obtaining kits from MiraDx, and then as patients are tested, filling out our online requisition for each patient before sending their kit in to MiraDx. Results will be returned within 3-5 business days.